Edoxaban Review Service W94024
Betsi Cadwaladr University Health BoardcontractFind a Tender ↗Ref ocds-h6vhtk-06c6ff32014L0024active
Estimated value
—
services
Awarded value
—
Suppliers
1
1 SME
Lots
1
1 awarded
Published
24 Jul 2026
Description
The service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.
Scope
- Reference
- BCU-MSP02-Edoxaban-W94024
- Commercial tool
- Standalone contract
- Contract dates
- 02 Aug 2026 to 31 Jan 2027
- Main category
- services
- CPV classifications
- 85121100
- Contract locations
- WalesWales
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| most suitable provider process with regard to the key criteria | 100 | quality | — |
| most suitable provider process with regard to the key criteria | pass | cost | — |
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Awarded suppliers· 1 supplier
Awarded —
Award value
—
Other contracts from Betsi Cadwaladr University Health Board
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Meddygfa Gwydir Surgery· 1
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Local Enhanced Clinical Effectiveness Service W94024 | contract | — | 15 Jul 2026 |